InMed Pharmaceuticals Inc. (INM) vs NeuroSense Therapeutics Ltd. (NRSN)

A side-by-side comparison of InMed Pharmaceuticals Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INM

InMed Pharmaceuticals Inc.

$7M

$1.33HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT

NRSN

NeuroSense Therapeutics Ltd.

$7M

$3.91HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

Total return — INM vs NRSN

growth of $100 · dividends reinvested · last 5y

INM -99.8% (-71.8%/yr)NRSN -95.0% (-45.1%/yr)NRSN compounded faster over this window

Log scale — wide-divergence pair

INM NRSN

INM vs NRSN: by the numbers

•INM is the larger company ($7M vs $7M market cap).
•Both run net losses; NRSN's is the smaller (0.00% vs -0.61% net margin).

Metrics side by side

Valuation

Metric	INM	NRSN
P/S ratio	0.00	N/A
P/B ratio	6.80	N/A

Profitability

Metric	INM	NRSN
Gross margin	14.92%	0.00%
Operating margin	-0.52%	0.00%
Net margin	-0.61%	0.00%
ROE	-1168.44%	N/A
ROIC	-995.44%	N/A

Growth (annualized)

Metric	INM	NRSN
Total return CAGR (5Y)	-71.98%	N/A

Go deeper

Full INM analysis Full NRSN analysis Interactive comparison tool

Dig into the metrics

InMed Pharmaceuticals ROE NeuroSense Therapeutics ROE InMed Pharmaceuticals operating margin NeuroSense Therapeutics operating margin InMed Pharmaceuticals revenue growth NeuroSense Therapeutics revenue growth InMed Pharmaceuticals free cash flow NeuroSense Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.